Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Candesartan cilexetil
Drug ID BADD_D00347
Description Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is administered orally as the prodrug, candesartan cilexetil, which is rapidly converted to its active metabolite, candesartan, during absorption in the gastrointestinal tract. Candesartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Candesartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease.
Indications and Usage Mendis B, Page SR: Candesartan: widening indications for this angiotensin II receptor blocker? Expert Opin Pharmacother. 2009 Aug;10(12):1995-2007. doi: 10.1517/14656560903092197.
Marketing Status Prescription; Discontinued
ATC Code C09CA06
DrugBank ID DB00796
KEGG ID D00626
MeSH ID C077793
PubChem ID 2540
TTD Drug ID Not Available
NDC Product Code 62559-640; 0378-3224; 62559-643; 62332-341; 49884-659; 0378-3225; 72761-002; 49884-660; 62559-641; 63629-2127; 46708-342; 49884-661; 0378-3232; 68382-191; 70771-1204; 63629-2126; 17228-0032; 62332-342; 70518-2719; 0378-3231; 60687-119; 62332-343; 46708-060; 70771-1207; 60687-241; 70771-1205; 68382-190; 17228-0017; 46708-343; 68382-192; 62559-642; 68382-193; 49884-658; 62332-060; 46708-877; 70771-1206; 17228-0016; 17228-0018; 70518-2884; 64220-114; 60687-130; 46708-341; 52562-100; 65372-1128
Synonyms candesartan cilexetil | 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate | 1H-benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)- | Parapres | Kenzen | Amias | Blopress | Atacand | TCV 116 | TCV-116
Chemical Information
Molecular Formula C33H34N6O6
CAS Registry Number 145040-37-5
SMILES CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC 6
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Liver function test abnormal13.03.01.0130.003855%Not Available
Loss of consciousness17.02.04.004--Not Available
Lung disorder22.02.07.0010.003855%Not Available
Malaise08.01.01.0030.032766%
Memory impairment19.20.01.003; 17.03.02.0030.007710%
Menopausal symptoms21.02.02.002--Not Available
Metabolic acidosis14.01.01.0030.007710%Not Available
Metastases to liver16.22.02.001; 09.04.02.0040.001006%Not Available
Microalbuminuria14.07.02.002; 20.02.01.026; 05.07.02.0020.003855%Not Available
Microcephaly03.11.02.002; 15.11.02.0020.003855%Not Available
Migraine24.03.05.003; 17.14.02.0010.011564%Not Available
Muscle atrophy17.05.03.004; 15.05.03.003--Not Available
Muscle haemorrhage24.07.01.037; 15.05.03.0170.005782%Not Available
Muscle rigidity17.05.02.005; 15.05.04.0010.003855%Not Available
Muscle spasms15.05.03.0040.017347%
Muscular weakness17.05.03.005; 15.05.06.0010.025056%
Myalgia15.05.02.0010.034693%
Myocardial infarction02.02.02.007; 24.04.04.009--
Myopathy15.05.05.001--Not Available
Myopia06.02.04.002--Not Available
Myositis15.05.01.001--
Nasal congestion22.04.04.0010.003855%
Nasopharyngitis22.07.03.002; 11.01.13.0020.007710%Not Available
Nausea07.01.07.001--
Nephrocalcinosis20.04.01.0010.003855%Not Available
Nephrolithiasis20.04.01.0020.007710%
Nephropathy20.05.03.001--Not Available
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Neurosis19.06.01.001--Not Available
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 15 Pages